Ophthalmology

Top Story

CooperVision studies myopia control using daily disposables in children

May 3, 2016

SEATTLE – “With every diopter of increase in myopia, you have an increased risk of ocular pathology,” according to Arthur Back, BOptom, PhD, FAAO.

Back, chief technology officer for CooperVision, told Primary Care Optometry News in an interview here at the Association for Research in Vision and Ophthalmology meeting that the company is working on a solution to control the progression of myopia in children through the use of daily disposable contact lenses.

Meeting News Coverage

Lower levels of vitamin D associated with increased risk of noninfectious uveitis

May 3, 2016
SEATTLE — Patients with noninfectious uveitis had lower levels of vitamin D compared to patients without noninfectious uveitis, according to a poster presented…
Meeting News Coverage

RNFL thickness correlated to cognitive function

May 3, 2016
SEATTLE – Researchers reported here at the Association for Research in Vision and Ophthalmology meeting that a thicker retinal nerve fiber layer was associated…
Meeting News Coverage

Compliance with contact lens care does not match awareness

May 3, 2016
SEATTLE – A survey of contact lens wearers showed that the majority said they receive information on contact lens care from their doctors; however, compliance is…
Meeting News CoverageVideo

VIDEO: PlayStation effective for amblyopia treatment

May 3, 2016
SEATTLE – Ricardo Torres-Vidal, of the Asociacion para Evitar la Ceguera en Mexico, discussed his study involving the use of PlayStation Portable in the treatment…
More News Headlines »
Original Article

Clinical Evaluation of Macular Thickness Changes in Cataract Surgery Using a Light-Adjustable Intraocular Lens

Journal of Refractive Surgery, April 2016, Volume 32 Issue 4
To detect changes in retinal perfusion and macular thickness using fluorescein angiography and spectral-domain optical…
More »
CME

Clinical Trials in Diabetic Retinopathy

This activity is supported by educational grants from Allergan, Inc.; Genentech, Inc.; and Regeneron Pharmaceuticals, Inc.

The advent of intravitreal therapies to treat retinal diseases has revolutionized the management of retinal pathology…
More »
Featured
Highlights from ARVO

Highlights from ARVO

Video
Meeting News Coverage

VIDEO: LALES study shows need for early AMD intervention for Latino population in US

May 1, 2016
More »
morganatic-roan